🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to compare two similar treatments for patients...
Status
Unknown
Location
BC Cancer Agency
Start Date
2004-05
Trial ID
NCT00175396
The purpose of this study is to determine whether multimodal nutrition ther...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2024-10-25
Trial ID
NCT05379712
Treatments Being Tested
This is a standard of care document, outlining the therapy for children wit...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-03-28
Trial ID
NCT01526603
* To evaluate the safety and tolerability of the dual IM pNGVL4a Sig/E7(det...
Status
Terminated
Location
Health Awareness, Inc.
Start Date
2019-05-22
Trial ID
NCT03911076
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Status
Terminated
Location
Tom Baker Cancer Centre
Start Date
2008-06-02
Trial ID
NCT00651326
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2011-07
Trial ID
NCT01368588
This trial will study the safety and tolerability and disease survival rate...
Status
Recruiting
Location
UPMC Hillman Cancer
Start Date
2026-04-06
Trial ID
NCT07423078
Treatments Being Tested
This is a single-center, prospective, randomized, controlled (crossover) cl...
Status
Withdrawn
Location
Columbia University Irving Medical Center
Start Date
2024-07-01
Trial ID
NCT06126354
Single center, open-label Proof of Principle phase II trial to assess objec...
Status
Withdrawn
Location
UO Immunoterapia e Laboratorio TCS, IRCCS IRST
Start Date
2016-03
Trial ID
NCT03226236
Treatments Being Tested
A randomized controlled open-label trial in patients with high risk prostat...
Status
Unknown
Location
Juravinski Cancer Centre
Start Date
2019-01-01
Trial ID
NCT03380806